Schedule 13G ownership disclosure
XILIO THERAPEUTICS INC
Security class unavailable · CUSIP: 98422T100
Event date: 2021-10-22
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 5.7000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-21-135061
- Form type
- SC 13G
- Filer
- RA CAPITAL MANAGEMENT, L.P.
- CIK
- CIK 1346824
- Filed
- Nov 05, 2021
- Reporting period
- Oct 22, 2021
- Description
- Schedule 13G beneficial ownership